Skip to main content
VCbacked
Log inGet Started

SwanBio Therapeutics

Bala Cynwyd, United States

SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.

$10.0M raised
Oct 2023
Venture - Series Unknown
Biotechnology

Top Investors

Partners Innovation FundMass General Brigham VenturesSyncona Partners LLP

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SwanBio Therapeutics

How much funding has SwanBio Therapeutics raised?
SwanBio Therapeutics has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Who are SwanBio Therapeutics's investors?
SwanBio Therapeutics's investors include Partners Innovation Fund, Mass General Brigham Ventures, Syncona Partners LLP.
Where is SwanBio Therapeutics headquartered?
SwanBio Therapeutics is headquartered in Bala Cynwyd, United States.
What does SwanBio Therapeutics do?
SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
What stage is SwanBio Therapeutics at?
SwanBio Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"SwanBio Therapeutics — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/swanbio-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2023). SwanBio Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/swanbio-therapeutics
Wikipedia (cite web)
{{cite web |title=SwanBio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/swanbio-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K